Beken Bio
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 4
About Beken Bio
Beken Bio, Inc.Beken Bio develops minimally invasive liquid biopsies that leverage its 3D REVEAL™ engine to identify novel cancer biomarkers in blood samples. Headquartered in San Diego, US, the company has undertaken strategic advancements in its technology. Beken Bio specializes in the development of minimally invasive liquid biopsies, utilizing its proprietary 3D REVEAL™ engine to diagnose cancer at its earliest stages. This innovative technology identifies novel cancer biomarkers present in the blood before symptoms manifest, enhancing early detection capabilities. The primary objective of Beken Bio’s offerings is to empower healthcare providers with accurate diagnostic tools, facilitating timely and effective treatment interventions for patients. The company targets a broad array of clients, including hospitals, diagnostic laboratories, and oncologists, focusing on markets in North America, Europe, and select regions in Asia.The revenue model of Beken Bio is structured around partnerships with healthcare providers and institutions that integrate its diagnostic solutions into their patient care workflows. The company engages in B2B transactions, supplying its liquid biopsy tests to hospitals and laboratories that then offer these services to their patients. Revenue is generated through the sale of its flagship product, the 3D REVEAL™ liquid biopsy, which is expected to be billed per diagnostic test performed. Pricing structures may be defined through subscription agreements or direct sales contracts, ensuring healthcare partners have access to the latest advancements in cancer detection technology. These transactional frameworks are designed to foster long-term relationships with clients, supporting a continuous revenue stream as the demand for early cancer detection solutions grows
Who invested in Beken Bio
4 investors across 1 round
See all investors in Beken Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 10, 2025
Amount
Undisclosed
Investors
Questions about Beken Bio
Who invested in Beken Bio?
Beken Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beken Bio raised?
Beken Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beken Bio last raise money?
Beken Bio's most recent round on record is a Seed, in Dec 2025.
What does Beken Bio do?
Beken Bio is a biotechnology company.
Where is Beken Bio headquartered?
Beken Bio is headquartered in San Diego, US.
Which VCs invest in companies like Beken Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Beken Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Beken Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.